{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:10:02Z","timestamp":1785409802269,"version":"3.56.0"},"reference-count":37,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M763334"],"award-info":[{"award-number":["2024M763334"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"award":["2024M763334"],"award-info":[{"award-number":["2024M763334"]}],"id":[{"id":"https:\/\/ror.org\/0426zh255","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>\u03b3-Tocotrienol (\u03b3-T3), a naturally occurring vitamin E isoform from plant-derived sources, has attracted attention as an antitumour agent. However, whether \u03b3-T3 can enhance antitumour immunity and improve immune checkpoint blockade remains unclear. Here, using colorectal cancer (CRC) models, we found that \u03b3-T3 suppressed tumour growth in immunocompetent MC38 and CT26 mouse models, whereas this effect was markedly weakened in immunodeficient hosts, indicating that its in vivo antitumour activity is closely associated with host immunity. Combination treatment with \u03b3-T3 and programmed cell death protein 1 (PD-1) blockade further improved tumour control, accompanied by enhanced CD8+ T cell effector function, reduced regulatory T cell abundance, and tumour-associated macrophage remodelling towards an antitumour phenotype. Immune cell depletion experiments confirmed that CD8+ T cells are the principal effector cells mediating \u03b3-T3-associated tumour suppression. Mechanistically, HSPA4 was identified as a candidate \u03b3-T3-associated protein potentially linked to MHC-I-related immune-recognition features. \u03b3-T3 promoted the expression of Psmb8 and Tap2 and increased MHC-I surface levels on tumour cells, accompanied by increased sensitivity of tumour cells to activated CD8+ T cell-mediated growth inhibition. These findings support \u03b3-T3 as a naturally derived immune-sensitising agent for improving PD-1 blockade therapy in CRC.<\/jats:p>","DOI":"10.3390\/biom16070964","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:06:34Z","timestamp":1782875194000},"page":"964","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b3-Tocotrienol Sensitises Colorectal Cancer to PD-1 Blockade by Enhancing MHC-I-Associated Tumour Immune Visibility and CD8+ T Cell-Related Antitumour Immunity"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7798-6723","authenticated-orcid":false,"given":"Haixia","family":"Wang","sequence":"first","affiliation":[{"name":"Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Chu","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Xu","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Li","sequence":"additional","affiliation":[{"name":"Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xie","sequence":"additional","affiliation":[{"name":"Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: Rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: Advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0140-6736(26)00686-0","article-title":"Ultra-processed food policy must regulate the screen as well as the street","volume":"407","author":"Hu","year":"2026","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.apsb.2021.08.020","article-title":"Emerging role of natural products in cancer immunotherapy","volume":"12","author":"Dong","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2453317","DOI":"10.1001\/jamanetworkopen.2024.53317","article-title":"Trends in Treatment Need and Receipt for Substance Use Disorders in the US","volume":"8","author":"Liu","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.3390\/ijms22126222","article-title":"Tocopherols and Tocotrienols-Bioactive Dietary Compounds; What Is Certain, What Is Doubt?","volume":"22","author":"Szewczyk","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jcp.27075","article-title":"Anticancer Properties of Tocotrienols: A Review of Cellular Mechanisms and Molecular Targets","volume":"234","author":"Macchi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4421336","DOI":"10.1155\/bmri\/4421336","article-title":"Inhibition of Proliferation and Induction of Apoptosis by Gamma- or Delta-Tocotrienols in Human Colorectal Carcinoma Cells","volume":"2025","author":"Khalid","year":"2025","journal-title":"BioMed Res. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cei.13650","article-title":"Reduced infiltration of regulatory T cells in tumours from mice fed daily with gamma-tocotrienol supplementation","volume":"206","author":"Subramaniam","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"de Mello Ramon, A., Abdul Hafid, S.R., Chakravarthi, S., Nesaretnam, K., and Radhakrishnan, A.K. (2013). Tocotrienol-Adjuvanted Dendritic Cells Inhibit Tumor Growth and Metastasis: A Murine Model of Breast Cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074753"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12943-023-01899-4","article-title":"Targeting MHC-I molecules for cancer: Function, mechanism, and therapeutic prospects","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/EDBK_240837","article-title":"Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?","volume":"39","author":"Fares","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: Insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1042\/BST20210961","article-title":"Regulation of the antigen presentation machinery in cancer and its implication for immune surveillance","volume":"50","author":"Balasubramanian","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.molcel.2026.05.005","article-title":"A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer","volume":"86","author":"Berquez","year":"2026","journal-title":"Mol. Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.mcpro.2022.100230","article-title":"MHC Class I Immunopeptidome: Past, Present, and Future","volume":"21","author":"Yewdell","year":"2022","journal-title":"Mol. Cell Proteom."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.coi.2016.04.002","article-title":"The source of MHC class I presented peptides and its implications","volume":"40","author":"Apcher","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"13","author":"Schubert","year":"2000","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1073\/pnas.1914401117","article-title":"Role for ribosome-associated quality control in sampling proteins for MHC class I-mediated antigen presentation","volume":"117","author":"Trentini","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molimm.2021.12.013","article-title":"Spotlight on TAP and its vital role in antigen presentation and cross-presentation","volume":"142","author":"Mantel","year":"2022","journal-title":"Mol. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1158\/1078-0432.CCR-19-0596","article-title":"Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation","volume":"25","author":"Jaeger","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cell.2008.05.022","article-title":"Structural basis for the cooperation of Hsp70 and Hsp110 chaperones in protein folding","volume":"133","author":"Polier","year":"2008","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-025-02498-z","article-title":"Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: A phase 2 trial and exploratory biomolecular study","volume":"11","author":"Zhang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1158\/2326-6066.CIR-18-0337","article-title":"Tumor Lymphatic Function Regulates Tumor Inflammatory and Immunosuppressive Microenvironments","volume":"7","author":"Kataru","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cmet.2021.02.007","article-title":"The phytochemical hyperforin triggers thermogenesis in adipose tissue via a Dlat-AMPK signaling axis to curb obesity","volume":"33","author":"Chen","year":"2021","journal-title":"Cell Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/s41467-023-37576-9","article-title":"Farrerol directly activates the deubiqutinase UCHL3 to promote DNA repair and reprogramming when mediated by somatic cell nuclear transfer","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1016\/j.apsb.2024.07.005","article-title":"Target fishing and mechanistic insights of the natural anticancer drug candidate chlorogenic acid","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1021\/acsaom.4c00486","article-title":"Modular Nanoparticle Platform for Solution-Phase Optical Sensing of Protein-Protein Interactions","volume":"3","author":"Zhou","year":"2025","journal-title":"ACS Appl. Opt. Mater."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.2016.257","article-title":"Gamma-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules","volume":"115","author":"Prasad","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: The cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.it.2014.01.002","article-title":"Re-examining class-I presentation and the DRiP hypothesis","volume":"35","author":"Rock","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tham, S.-Y., Loh, H.-S., Mai, C.-W., and Fu, J. (2019). Tocotrienols Modulate a Life or Death Decision in Cancers. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020372"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hu, Y., Han, J., and Liu, M. (2026). Protocol-aware epidemic forecasting across heterogeneous public health surveillance systems. Front. Public Health, 14.","DOI":"10.3389\/fpubh.2026.1829302"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/7\/964\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:33:08Z","timestamp":1783053188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/7\/964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["biom16070964"],"URL":"https:\/\/doi.org\/10.3390\/biom16070964","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]}}}